Skip to content
Med Pharma News

Med Pharma News

Your Daily Dose of Pharma News

  • About Med Pharma News
  • Contact Us
  • News
  • Privacy Policy
  • Terms and Conditions
  • Home
  • chronic spontaneous urticaria

Tag: chronic spontaneous urticaria

Barzolvolimab atopic dermatitis Phase 2 results infographic
  • Pharmaceuticals

Barzolvolimab Atopic Dermatitis Trial Fails: Celldex Drops Eczema to Focus on Hives

Megan Wood5 hours ago5 hours ago09 mins

Celldex is ending barzolvolimab development in atopic dermatitis after a 131-patient Phase 2 missed its itch endpoint at both doses. The data, the biology behind the miss and what remains in the pipeline.

Read More

Categories

  • Healthcare IT (26)
  • Industry Insights (368)
  • Lifestyle and Wellness (24)
  • Medical Devices (45)
  • Pharmaceuticals (116)
  • Uncategorized (1)

Recent Posts

  • MAHA ELEVATE Model: CMS Awards $47M to 15 Groups to Test Lifestyle Medicine in Medicare
  • Rasonque EU Approval: Daraxonrasib Becomes Europe’s First RAS Pill for Pancreatic Cancer
  • Barzolvolimab Atopic Dermatitis Trial Fails: Celldex Drops Eczema to Focus on Hives
  • Savara Molgramostim FDA Decision Delayed: No New Date for First aPAP Drug
  • Xanamem Alzheimer’s Trial Misses Main Goal, Actinogen Shares Plunge Over 80%
Digital Newspaper - Multipurpose News WordPress Theme 2026. Powered By BlazeThemes.